L. Bras, J. Musset, L. Clain, and J. , Les r??sistances aux??m??dicaments antipaludiques, M??decine et Maladies Infectieuses, vol.36, issue.8, pp.401-405, 2006.
DOI : 10.1016/j.medmal.2006.05.005

N. White, Preventing antimalarial drug resistance through combinations, Drug Resistance Updates, vol.1, issue.1, pp.3-9, 2001.
DOI : 10.1016/S1368-7646(98)80208-2

J. Ndiaye, F. B. Gueye, A. Tine, R. Ndiaye, D. Tchania et al., Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial, Malaria Journal, vol.10, issue.1, p.237, 2011.
DOI : 10.1111/j.1365-3156.2008.02119.x

S. Thiam, M. Thior, F. B. Diouf, M. Diouf, M. Diallo et al., Major Reduction in Anti-Malarial Drug Consumption in Senegal after Nation-Wide Introduction of Malaria Rapid Diagnostic Tests, PLoS ONE, vol.83, issue.4, p.18419, 2011.
DOI : 10.1371/journal.pone.0018419.t002

L. Gadiaga, V. Machault, F. Pagès, A. Gaye, F. Jarjaval et al., Conditions of malaria transmission in Dakar from 2007 to 2010, Malaria Journal, vol.10, issue.1, p.312, 2007.
DOI : 10.1603/0022-2585(2005)042[0104:COHCAO]2.0.CO;2

P. Drame, V. Machault, A. Diallo, S. Cornélie, A. Poinsignon et al., IgG responses to the gSG6-P1 salivary peptide for evaluating human exposure to Anopheles bites in urban areas of Dakar region, S??n??gal, Malaria Journal, vol.11, issue.1, p.72, 2012.
DOI : 10.1016/j.ibmb.2006.11.005

A. Diallo, N. Ndam, A. Moussiliou, D. Santos, S. Ndonky et al., Asymptomatic Carriage of Plasmodium in Urban Dakar: The Risk of Malaria Should Not Be Underestimated, PLoS ONE, vol.48, issue.2, p.31300, 2012.
DOI : 10.1371/journal.pone.0031100.t004

URL : https://hal.archives-ouvertes.fr/halshs-00756465

L. Ministère-de and . Santé-et-de-la-prévention, Rapport sur la morbidité et la mortalité palustre au Sénégal en Dakar: Programme National de Lutte contre le Paludisme, 2008.

D. Fidock, T. Nomura, A. Talley, R. Cooper, S. Dzekunov et al., Mutations in the P. falciparum Digestive Vacuole Transmembrane Protein PfCRT and Evidence for Their Role in Chloroquine Resistance, Molecular Cell, vol.6, issue.4, pp.861-871, 2000.
DOI : 10.1016/S1097-2765(05)00077-8

J. Zolg, J. Plitt, G. Chen, and S. Palmer, Point mutations in the dihydrofolate reductase-thymidylate synthase gene as the molecular basis for pyrimethamine resistance in Plasmodium falciparum, Molecular and Biochemical Parasitology, vol.36, issue.3, pp.253-262, 1989.
DOI : 10.1016/0166-6851(89)90173-4

P. Wang, M. Read, P. Sims, and J. Hyde, Sulfadoxine resistance in the human malaria parasite Plasmodium falciparum is determined by mutations in dihydropteroate synthetase and an additional factor associated with folate utilization, Molecular Microbiology, vol.23, issue.5, pp.979-986, 1997.
DOI : 10.1046/j.1365-2958.1997.2821646.x

R. Price, C. Cassar, A. Brockman, M. Duraisingh, M. Van-vugt et al., The pfmdr1 gene is associated with a multidrugresistant phenotype in Plasmodium falciparum from the Western border of Thailand, Antimicrob Agents Chemother, vol.43, pp.2943-2949, 1999.

M. Henry, S. Alibert, E. Orlandi-pradines, H. Bogreau, T. Fusai et al., Chloroquine Resistance Reversal Agents as Promising Antimalarial Drugs, Current Drug Targets, vol.7, issue.8, pp.935-948, 2006.
DOI : 10.2174/138945006778019372

M. Henry, S. Alibert, C. Rogier, J. Barbe, and B. Pradines, Inhibition of Efflux of Quinolines as New Therapeutic Strategy in Malaria, Current Topics in Medicinal Chemistry, vol.8, issue.7, pp.563-578, 2008.
DOI : 10.2174/156802608783955593

H. Nagesha, G. Casey, H. Rieckmann, D. Fryauff, B. Laksana et al., New haplotypes of the Plasmodium falciparum chloroquine resistance transporter (pfcrt) gene among chloroquineresistant parasite isolates, Am J Trop Med Hyg, vol.68, pp.398-402, 2003.

D. Johnson, D. Fidock, M. Mungthin, V. Lakshmanan, A. Sidhu et al., Evidence for a Central Role for PfCRT in Conferring Plasmodium falciparum Resistance to Diverse Antimalarial Agents, Molecular Cell, vol.15, issue.6, pp.867-877, 2004.
DOI : 10.1016/j.molcel.2004.09.012

S. Picot, P. Olliaro, F. De-monbrison, A. Bienvenu, R. Price et al., A systematic review and meta-analysis of evidence for correlation between molecular markers of parasite resistance and treatment outcome in falciparum malaria, Malaria Journal, vol.8, issue.1, p.89, 2009.
DOI : 10.1186/1475-2875-8-89

C. Sibley, J. Hyde, P. Sims, C. Plowe, J. Kublin et al., Pyrimethamine???sulfadoxine resistance in Plasmodium falciparum: what next?, Trends in Parasitology, vol.17, issue.12, pp.582-588, 2001.
DOI : 10.1016/S1471-4922(01)02085-2

Y. Zhang and S. Meshnick, Inhibition of Plasmodium falciparum dihydropteroate synthetase and growth in vitro by sulfa drugs., Antimicrobial Agents and Chemotherapy, vol.35, issue.2, pp.267-271, 1991.
DOI : 10.1128/AAC.35.2.267

L. Basco and P. Ringwald, Molecular epidemiology of malaria in Yaoundé, Cameroon. III. Analysis of chloroquine resistance and point mutations in the multidrug resistance 1 (pfmdr 1) gene of Plasmodium falciparum, Am J Trop Med Hyg, vol.59, pp.577-581, 1998.

M. Duraisingh, C. Drakeley, O. Muller, R. Bailey, G. Snounou et al., Evidence for selection for the tyrosine-86 allele of the pfmdr 1 gene of Plasmodium falciparum by chloroquine and amodiaquine, Parasitology, vol.114, issue.3, pp.205-211, 1997.
DOI : 10.1017/S0031182096008487

S. Foote, D. Kyle, R. Martin, A. Oduola, K. Forsyth et al., Several alleles of the multidrug-resistance gene are closely linked to chloroquine resistance in Plasmodium falciparum, Nature, vol.345, issue.6272, pp.255-258, 1990.
DOI : 10.1038/345255a0

M. Grobusch, I. Adagu, P. Kremsner, and D. Warhurst, Plasmodium falciparum: in vitro chloroquine susceptibility and allele-specific PCR detection of Pfmdr1 Asn86Tyr polymorphism in Lambarene, Gabon, Parasitology, vol.116, issue.3, pp.211-217, 1998.
DOI : 10.1017/S0031182097002266

L. Basco, P. De-pecoulas, L. Bras, J. Wilson, and E. , Plasmodium falciparum:Molecular Characterization of Multidrug-Resistant Cambodian Isolates, Experimental Parasitology, vol.82, issue.2, pp.97-103, 1996.
DOI : 10.1006/expr.1996.0013

J. Marfurt, I. Muller, A. Sie, O. Oa, J. Reeder et al., The usefulness of twenty-four molecular markers in predicting treatment Fall et al Page 9 of 11 http://www.malariajournal.com/content/12/1/107 outcome with combination therapy of amodiaquine plus sulphadoxinepyrimethamine against falciparum malaria in Papua New Guinea, Malaria Journal Malar J, vol.12, issue.7, p.10761, 2008.

S. Ruetz, U. Delling, M. Brault, E. Schurr, and P. Gros, The pfmdr1 gene of Plasmodium falciparum confers cellular resistance to antimalarial drugs in yeast cells., Proceedings of the National Academy of Sciences, vol.93, issue.18, pp.9942-9947, 1996.
DOI : 10.1073/pnas.93.18.9942

M. Reed, K. Saliba, S. Caruana, K. Kirk, and A. Cowman, Pgh1 modulates sensitivity and resistance to multiple antimalarials in Plasmodium falciparum, Nature, vol.403, pp.906-909, 2000.

D. Pillai, G. Hijar, I. Montoya, W. Marquino, T. Ruebush et al., Lack of prediction of mefloquine and mefloquine-artesunate treatment outcome by mutations in the Plasmodium falciparum multidrug resistance 1 (pfmdr1) gene for P. falciparum malaria in Peru

M. Duraisingh, P. Jones, I. Sambou, L. Von-seidlein, M. Pinder et al., The tyrosine-86 allele of the pfmdr1 gene of Plasmodium falciparum is associated with increased sensitivity to the anti-malarials mefloquine and artemisinin, Molecular and Biochemical Parasitology, vol.108, issue.1, pp.13-23, 2000.
DOI : 10.1016/S0166-6851(00)00201-2

M. Duraisingh, C. Roper, D. Walliker, and D. Warhurst, Increased sensitivity to the antimalarials mefloquine and artemisinin is conferred by mutations in the pfmdr1 gene of Plasmodium falciparum, Molecular Microbiology, vol.75, issue.4, pp.955-961, 2000.
DOI : 10.1016/0166-6851(93)90252-S

C. Lambros and J. Vanderberg, Synchronization of Plasmodium falciparum Erythrocytic Stages in Culture, The Journal of Parasitology, vol.65, issue.3, pp.418-420, 1979.
DOI : 10.2307/3280287

H. Bogreau, F. Renaud, H. Bouchiba, P. Durand, S. Assi et al., Genetic diversity and structure of African Plasmodium falciparum populations in urban and rural areas, Am J Trop Med Hyg, vol.74, pp.953-959, 2006.

M. Henry, I. Diallo, J. Bordes, S. Ka, B. Pradines et al., Urban malaria in Dakar, Senegal: chemosusceptibility and genetic diversity of Plasmodium falciparum isolates, Am J Trop Med Hyg, vol.75, pp.146-151, 2006.

A. Pascual, L. Basco, E. Baret, R. Amalvict, D. Travers et al., Use of the atmospheric generators for capnophilic bacteria Genbag-CO2 for the evaluation of in vitro Plasmodium falciparum susceptibility to standard anti-malarial drugs, Malaria Journal, vol.10, issue.1, p.8, 2011.
DOI : 10.1186/1475-2875-10-8

H. Kaddouri, S. Nakache, S. Houzé, F. Mentré, L. Bras et al., Assessment of the Drug Susceptibility of Plasmodium falciparum Clinical Isolates from Africa by Using a Plasmodium Lactate Dehydrogenase Immunodetection Assay and an Inhibitory Maximum Effect Model for Precise Measurement of the 50-Percent Inhibitory Concentration, Antimicrobial Agents and Chemotherapy, vol.50, issue.10, pp.3343-3349, 2006.
DOI : 10.1128/AAC.00367-06

L. Nagard, H. Vincent, C. Mentré, F. , L. Bras et al., Online analysis of in vitro resistance to antimalarial drugs through nonlinear regression, Computer Methods and Programs in Biomedicine, vol.104, issue.1, pp.10-18, 2011.
DOI : 10.1016/j.cmpb.2010.08.003

URL : https://hal.archives-ouvertes.fr/inserm-00521869

H. Tinto, J. Ouédraogo, E. A. Van-overmeir, C. Dujardin, J. Van-marck et al., Relationship between the Pfcrt T76 and the Pfmdr-1 Y86 mutations in Plasmodium falciparum and in vitro/in vivo chloroquine resistance in Burkina Faso, West Africa, vivo chloroquine resistance in Burkina Faso, pp.287-292, 2003.
DOI : 10.1016/j.meegid.2003.08.002

L. Basco and P. Ringwald, Molecular epidemiology of malaria in Cameroon.X. Evaluation of Pfmdr1 mutations as genetic markers for resistance to amino alcohols and artemisinin derivatives, Am J. Trop Med Hyg, vol.66, pp.667-671, 2002.

B. Fall, S. Diawara, K. Sow, E. Baret, B. Diatta et al., Ex vivo susceptibility of Plasmodium falciparum isolates from Dakar, Senegal, to seven standard anti-malarial drugs, Malaria Journal, vol.10, issue.1, p.310, 2011.
DOI : 10.1128/AAC.45.6.1746-1750.2001

R. Jambou, E. Legrand, M. Niang, N. Khim, P. Lim et al., Resistance of Plasmodium falciparum field isolates to in-vitro artemether and point mutations of the SERCA-type PfATPase6, The Lancet, vol.366, issue.9501, pp.1960-1963, 2005.
DOI : 10.1016/S0140-6736(05)67787-2

URL : https://hal.archives-ouvertes.fr/pasteur-00590989

B. Pradines, C. Rogier, T. Fusai, A. Tall, and J. Doury, Sensibilité in vitro de 85 isolats de Plasmodium falciparum au Sénégal, Med Trop, vol.56, pp.141-145, 1996.

B. Pradines, A. Tall, C. Rogier, A. Spiegel, J. Mosnier et al., In vitro activities of ferrochloroquine against 55 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs, Tropical Medicine and International Health, vol.82, issue.3, pp.265-270, 2002.
DOI : 10.1016/S0764-4469(98)80009-7

B. Pradines, M. Mamfoumbi, M. Tall, A. Sokhna, C. Koeck et al., In Vitro Activity of Tafenoquine against the Asexual Blood Stages of Plasmodium falciparum Isolates from Gabon, Senegal, and Djibouti, vitro activity of tafenoquine against the asexual blood stages of Plasmodium falciparum isolates from Gabon, Senegal, and Djibouti, pp.3225-3226, 2006.
DOI : 10.1128/AAC.00777-06

I. Hatin, J. Trape, F. Legros, J. Bauchet, L. Bras et al., Susceptibility of Plasmodium falciparum strains to mefloquine in an urban area in Senegal, Bull World Health Organ, vol.70, pp.363-367, 1992.

C. Sokhna, J. Molez, P. Ndiaye, B. Sane, and J. Trape, Tests in vivo de chimiosensibilite de Plasmodium falciparum à la chloroquine au Sénégal: évolution de la résistance et estimation de l'efficacité thérapeutique, Bull Soc Pathol Exot, vol.90, pp.83-89, 1997.

B. Pradines, C. Rogier, T. Fusai, A. Tall, J. Trape et al., In vitro activity of artemether against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial drugs, Am J Trop Med Hyg, vol.58, pp.354-357, 1998.

B. Pradines, A. Tall, D. Parzy, A. Spiegel, T. Fusai et al., In-vitro activity of pyronaridine and amodiaquine against African isolates (Senegal) of Plasmodium falciparum in comparison with standard antimalarial agents., Journal of Antimicrobial Chemotherapy, vol.42, issue.3, pp.333-339, 1998.
DOI : 10.1093/jac/42.3.333

B. Pradines, A. Tall, F. Ramiandrasoa, A. Spiegel, C. Sokhna et al., In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum, Journal of Antimicrobial Chemotherapy, vol.57, issue.6, pp.1093-1099, 2006.
DOI : 10.1093/jac/dkl117

D. Ndiaye, V. Patel, A. Demas, M. Leroux, O. Ndir et al., A Non-Radioactive DAPI-based High-Throughput In Vitro Assay to Assess Plasmodium falciparum Responsiveness to Antimalarials--Increased Sensitivity of P. falciparum to Chloroquine in Senegal, American Journal of Tropical Medicine and Hygiene, vol.82, issue.2, pp.228-230, 2010.
DOI : 10.4269/ajtmh.2010.09-0470

A. Djimdé, O. Doumbo, J. Cortese, K. Kayentao, S. Doumbo et al., Amo le cul ar marker for chloroquine-resistant falciparum malaria, pp.257-263

M. Niang, L. Marrama, M. Ekala, A. Gaye, A. Tall et al., Accumulation of CVIET Pfcrt allele of Plasmodium falciparum in placenta of pregnant women living in an urban area of Dakar, Senegal, Journal of Antimicrobial Chemotherapy, vol.62, issue.5, pp.921-928, 2008.
DOI : 10.1093/jac/dkn299

S. Thomas, O. Ndir, T. Dieng, S. Mboup, D. Wypij et al., In vitro chloroquine susceptibility and PCR analysis of pfcrt and pfmdr1 polymorphisms in Plasmodium falciparum isolates from Senegal, Am J Trop Med Hyg, vol.66, pp.474-480, 2002.

O. Sarr, A. Myrick, J. Daily, B. Diop, T. Dieng et al., In vivo and in vitro analysis of chloroquine resistance in Plasmodium falciparum isolates from Senegal, Parasitology Research, vol.57, issue.Pt 3, pp.136-140, 2005.
DOI : 10.1007/s00436-005-1406-7

O. Sarr, A. Ahouidi, O. Ly, J. Daily, D. Ndiaye et al., Mutations in PFCRT K76T do not correlate with sulfadoxine???pyrimethamine???amodiaquine failure in Pikine, Senegal, Parasitology Research, vol.73, issue.4, pp.765-769, 2008.
DOI : 10.1007/s00436-008-1038-9

G. Bertin, N. Ndam, S. Jafari-guemouri, N. Fievet, E. Renart et al., High prevalence of Plasmodium falciparum pfcrt K76T mutation in pregnant women taking chloroquine prophylaxis in Senegal, Journal of Antimicrobial Chemotherapy, vol.55, issue.5, pp.788-791, 2005.
DOI : 10.1093/jac/dki097

N. Wurtz, B. Fall, A. Pascual, S. Diawara, K. Sow et al., Prevalence of molecular markers of Plasmodium falciparum drug resistance in Dakar, Senegal, Malaria Journal, vol.11, issue.1, p.197, 2012.
DOI : 10.1016/j.pt.2007.09.008

URL : https://hal.archives-ouvertes.fr/pasteur-00836693

M. Ndiaye, F. B. Tine, R. Ndiaye, J. Lo, A. Abiola et al., Assessment of the Molecular Marker of Plasmodium falciparum Chloroquine Resistance (Pfcrt) in Senegal after Several Years of Chloroquine Withdrawal, American Journal of Tropical Medicine and Hygiene, vol.87, issue.4, pp.640-645, 2012.
DOI : 10.4269/ajtmh.2012.11-0709

O. Ly, P. Gueye, A. Deme, T. Dieng, A. Badiane et al., Evolution of the pfcrt T76 and pfmdr1 Y86 markers and chloroquine susceptibility 8??years after cessation of chloroquine use in Pikine, Senegal, Parasitology Research, vol.72, issue.8, pp.1541-1546, 2012.
DOI : 10.1007/s00436-012-2994-7

F. Gardella, S. Assi, F. Simon, H. Bogreau, T. Eggelte et al., Antimalarial drug use in general populations of tropical Africa, Malaria Journal, vol.7, issue.1, p.124, 2008.
DOI : 10.1186/1475-2875-7-124

A. Frosch, M. Venkatesan, and M. Laufer, Patterns of chloroquine use and resistance in sub-Saharan Africa: a systematic review of household survey and molecular data, Malaria Journal, vol.10, issue.1, p.116, 2011.
DOI : 10.1086/655659

L. Ministère-de and . Santé-et-de-la-prévention-médicale, Enquête nationale sur le paludisme au Sénégal, 2006.

L. Ministère-de and . Santé-et-de-la-prévention-médicale, Enquête nationale sur le paludisme au Sénégal, 2008.

J. Kublin, J. Cortese, E. Njunju, R. Mukadam, J. Wirima et al., Malaria after Cessation of Chloroquine Use in Malawi, The Journal of Infectious Diseases, vol.187, issue.12, pp.1870-1875, 2003.
DOI : 10.1086/375419

M. Laufer, P. Thesing, N. Eddington, R. Masonga, F. Dzinjalamala et al., Return of Chloroquine Antimalarial Efficacy in Malawi, New England Journal of Medicine, vol.355, issue.19, pp.1959-1966, 2006.
DOI : 10.1056/NEJMoa062032

N. Noranate, R. Durand, A. Tall, L. Marrama, A. Spiegel et al., Rapid Dissemination of Plasmodium falciparum Drug Resistance Despite Strictly Controlled Antimalarial Use, PLoS ONE, vol.2, issue.1, p.139, 2007.
DOI : 10.1371/journal.pone.0000139.s003

P. Agnamey, P. Brasseur, E. De-pecoulas, M. Vaillant, and P. Olliaro, Plasmodium falciparum In Vitro Susceptibility to Antimalarial Drugs in Casamance (Southwestern Senegal) during the First 5 Years of Routine Use of Artesunate-Amodiaquine, Antimicrobial Agents and Chemotherapy, vol.50, issue.4, pp.1531-1534, 2006.
DOI : 10.1128/AAC.50.4.1531-1534.2006

G. Holmgren, J. Gil, P. Ferreira, M. Veiga, C. Obonyo et al., Amodiaquine resistant Plasmodium falciparum malaria in vivo is associated with selection of pfcrt 76T and pfmdr1 86Y, Infection, Genetics and Evolution, vol.6, issue.4, pp.309-314, 2006.
DOI : 10.1016/j.meegid.2005.09.001

S. Nsobya, C. Dokomajilar, M. Joloba, G. Dorsey, and P. Rosenthal, Resistance-Mediating Plasmodium falciparum pfcrt and pfmdr1 Alleles after Treatment with Artesunate-Amodiaquine in Uganda, Antimicrobial Agents and Chemotherapy, vol.51, issue.8, pp.3023-3025, 2007.
DOI : 10.1128/AAC.00012-07

D. Echeverry, G. Holmgren, C. Murillo, J. Higuita, J. Gil et al., Polymorphisms in the pfcrt and pfmdr1 genes of Plasmodium falciparum and in vitro susceptibility to amodiaquine and desethylamodiaquine, Am J Trop Med Hyg, vol.77, pp.1034-1038, 2007.

I. Danquah, B. Coulibaly, P. Meissner, I. Petruschke, O. Muller et al., Selection of pfmdr1 and pfcrt alleles in amodiaquine treatment failure in north-western Burkina Faso, Acta Tropica, vol.114, issue.1, pp.63-96, 2010.
DOI : 10.1016/j.actatropica.2009.12.008

P. Brasseur, R. Guiguemde, S. Diallo, V. Guiyedi, M. Kombila et al., Amodiaquine remains effective for treating uncomplicated malaria in West and Central Africa, Transactions of the Royal Society of Tropical Medicine and Hygiene, vol.93, issue.6, pp.645-650, 1999.
DOI : 10.1016/S0035-9203(99)90083-4

J. Ndiaye, F. B. Diouf, A. Kuété, T. Cisse, M. Seck et al., Randomized, comparative study of the efficacy and safety of artesunate plus amodiaquine, administered as a single daily intake versus two daily intakes in the treatment of uncomplicated falciparum malaria, Malaria Journal, vol.7, issue.1, p.16, 2008.
DOI : 10.1186/1475-2875-7-16

J. Ndiaye, M. Randrianarivelojosia, I. Sagara, P. Brasseur, I. Ndiaye et al., Randomized, multicentre assessment of the efficacy and safety of ASAQ ??? a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria, Malaria Journal, vol.8, issue.1, p.125, 2009.
DOI : 10.1186/1475-2875-8-125

A. Dondorp, F. Nosten, P. Yi, D. Das, A. Phyo et al., Malaria, New England Journal of Medicine, vol.361, issue.5, pp.455-467, 2009.
DOI : 10.1056/NEJMoa0808859

URL : https://hal.archives-ouvertes.fr/hal-01199794

H. Noedl, Y. Se, K. Schaecher, B. Smith, D. Socheat et al., Evidence of Artemisinin-Resistant Malaria in Western Cambodia, New England Journal of Medicine, vol.359, issue.24, pp.2619-2620, 2008.
DOI : 10.1056/NEJMc0805011

C. Sibley, K. Barnes, and C. Plowe, The rationale and plan for creating a World Antimalarial Resistance Network (WARN), Malaria Journal, vol.6, issue.1, p.118, 2007.
DOI : 10.1186/1475-2875-6-118

C. Sibley, K. Barnes, W. Watkins, and C. Plowe, A network to monitor antimalarial drug resistance: a plan for moving forward, Trends in Parasitology, vol.24, issue.1, pp.43-48, 2008.
DOI : 10.1016/j.pt.2007.09.008

B. Pradines, A. Tall, T. Fusai, A. Spiegel, R. Hienne et al., In vitro activities of benflumetol against 158 Senegalese isolates of Plasmodium falciparum in comparison with those of standard antimalarial drugs, Antimicrob Agents Chemother, vol.43, pp.418-420, 1999.

O. Brandicourt, P. Druilhe, F. Diouf, P. Brasseur, P. Turk et al., Decreased sensitivity to chloroquine and quinine of some Plasmodium falciparum strains from Senegal in, Am J Trop Med Hyg, vol.35, pp.717-721, 1984.

T. Jelinek, P. Schelbert, T. Loscher, and D. Eichenlaub, Quinine resistant falciparum malaria acquired in east Africa, Trop Med Parasitol, vol.46, pp.38-40, 1995.

F. Palmieri, N. Petrosillo, M. Paglia, A. Conte, D. Goletti et al., Genetic Confirmation of Quinine-Resistant Plasmodium falciparum Malaria Followed by Postmalaria Neurological Syndrome in a Traveler from Mozambique, Journal of Clinical Microbiology, vol.42, issue.11, pp.5424-5426, 2004.
DOI : 10.1128/JCM.42.11.5424-5426.2004

B. Pradines, T. Pistone, K. Ezzedine, S. Briolant, L. Bertaux et al., Quinine-Resistant Malaria in Traveler Returning from Senegal, 2007, Emerging Infectious Diseases, vol.16, issue.3, pp.546-548, 2007.
DOI : 10.3201/eid1603.091669

B. Pradines, A. Spiegel, C. Rogier, A. Tall, J. Mosnier et al., Antibiotics for prophylaxis of Plasmodium falciparum infections: in vitro activity of doxycycline against Senegalese isolates, Am J Trop Med Hyg, vol.62, pp.82-85, 2000.

S. Briolant, M. Baragatti, P. Parola, F. Simon, A. Tall et al., Multinormal In Vitro Distribution Model Suitable for the Distribution of Plasmodium falciparum Chemosusceptibility to Doxycycline, Antimicrobial Agents and Chemotherapy, vol.53, issue.2, pp.688-695, 2009.
DOI : 10.1128/AAC.00546-08

B. Pradines, C. Rogier, T. Fusai, J. Mosnier, W. Daries et al., In Vitro Activities of Antibiotics against Plasmodium falciparum Are Inhibited by Iron, Antimicrobial Agents and Chemotherapy, vol.45, issue.6, pp.1746-1750, 2001.
DOI : 10.1128/AAC.45.6.1746-1750.2001

D. Ndiaye, J. Dailly, O. Sarr, O. Ndir, O. Gaye et al., Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase genes in Senegal, Tropical Medicine and International Health, vol.147, issue.11, pp.1176-1179, 2005.
DOI : 10.1016/S1473-3099(02)00239-6

B. Cissé, M. Cairns, E. Faye, O. Ndiaye, F. B. Cames et al., Randomized Trial of Piperaquine with Sulfadoxine-Pyrimethamine or Dihydroartemisinin for Malaria Intermittent Preventive Treatment in Children, PLoS ONE, vol.25, issue.1, p.7164, 2009.
DOI : 10.1371/journal.pone.0007164.s002

B. Faye, M. Ndiaye, J. Ndiaye, A. A. Tine, R. et al., Prevalence of molecular markers of Plasmodium falciparum resistance to sulfadoxine???pyrimethamine during the intermittent preventive treatment in infants coupled with the expanded program immunization in Senegal, Parasitology Research, vol.10, issue.6, pp.133-138, 2011.
DOI : 10.1007/s00436-010-2236-9

C. Sokhna, B. Cissé, E. Ba, P. Milligan, R. Hallett et al., A Trial of the Efficacy, Safety and Impact on Drug Resistance of Four Drug Regimens for Seasonal Intermittent Preventive Treatment for Malaria in Senegalese Children, PLoS ONE, vol.91, issue.1, p.1471, 2008.
DOI : 10.1371/journal.pone.0001471.s002

B. Cissé, C. Sokhna, D. Boulanger, J. Milet, E. Ba et al., Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial, The Lancet, vol.367, issue.9511, pp.659-667, 2006.
DOI : 10.1016/S0140-6736(06)68264-0